Quarterly Result14 May 2026, 04:51 pm
Global Health Ltd Approves FY26 Audited Results, Recommends ₹0.50 Dividend
AI Summary
Global Health Limited (GHL) has approved its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The board has recommended a final dividend of ₹0.50 (25%) per equity share, subject to shareholder approval at the AGM. The company also announced the appointment of Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel, both effective May 14, 2026. The resignation of Ms. Richa Singh as SMP of the Company w.e.f. May 20, 2026 was noted.
Key Highlights
- GHL approves audited FY26 standalone and consolidated financial results.
- Final dividend of ₹0.50 per share recommended, pending shareholder approval.
- Kedar Ashok Apte appointed as Chief Marketing & Growth Officer.
- Jagdeep Singh appointed as General Counsel.
- Richa Singh's resignation as SMP noted, effective May 20, 2026.
Price Impact
More from MEDANTA